Precision therapy. Personalized care.
We are passionate about targeted cancer care expertly tailored to meet patients’ personalized needs. We carefully designed the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to empower physicians with full confidence to precisely and effectively treat cancer and enable patients to live healthy, high-quality lives.
From the Newsroom
August 29, 2018
iCAD Announces AERB Approval of Xoft System in India
Breast IORT Case Study
Leading global centers select the Xoft System for treatment of early-stage breast cancer
Multiple factors including clinically-proven efficacy, shorter treatment time, greater flexibility, easy portability and lower cost drive adoption
Medical City Plano, a HCA Healthcare Facility, becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care.
Discover the growing body of favorable clinical data supporting the use of electronic brachytherapy (eBx) in patients meeting specific selection criteria.
Discover our Advanced, Multi-Platform System
©2018 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.